首页> 中文期刊> 《癌症生物学与医学:英文版 》 >NLRP6 is correlated with the progression and therapeutic outcome of hepatocellular carcinoma and inhibits the function of CD14^+ cells

NLRP6 is correlated with the progression and therapeutic outcome of hepatocellular carcinoma and inhibits the function of CD14^+ cells

             

摘要

Objective:Inflammasomes promote carcinogenesis through an extrinsic pathway and maintain the malignant cancer microenvironment through an intrinsic pathway.Moreover,inflammasomes exert anticancer effects by pyroptosis and immune regulatory functions.Until now,there have been few studies about how inflammasomes contribute to hepatocellular carcinoma(HCC)development.

著录项

  • 来源
    《癌症生物学与医学:英文版 》 |2018年第s01期|P.6-6|共1页
  • 作者单位

    Comprehensive Liver Cancer Center The 302 Hospital Beijing China;

    Comprehensive Liver Cancer Center The 302 Hospital Beijing China;

    Center for Biotherapeutic Research The 302 Hospital Beijing China;

    Comprehensive Liver Cancer Center The 302 Hospital Beijing China;

    Comprehensive Liver Cancer Center The 302 Hospital Beijing China;

    Comprehensive Liver Cancer Center The 302 Hospital Beijing China;

    Comprehensive Liver Cancer Center The 302 Hospital Beijing China;

    Comprehensive Liver Cancer Center The 302 Hospital Beijing China;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 肝肿瘤 ;
  • 关键词

    NLRP6; progression; therapeutic;

    机译:nlrp6;进展;治疗;
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号